We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
+11.81%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$99M
AUM Growth
+$15.7M
(+19%)
Cap. Flow
+$7.99M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
41.42%
Holding
71
New
10
Increased
19
Reduced
22
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMLR
Semler Scientific
SMLR
|
+$1.39M |
| 2 |
EFII
Electronics for Imaging
EFII
|
+$1.27M |
| 3 |
Akebia Therapeutics
AKBA
|
+$1M |
| 4 |
Digital Turbine
APPS
|
+$857K |
| 5 |
CLLS
Cellectis
CLLS
|
+$789K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WEB
Web.com Group, Inc.
WEB
|
+$2.17M |
| 2 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$991K |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$809K |
| 4 |
Chegg
CHGG
|
+$754K |
| 5 |
Varonis Systems
VRNS
|
+$719K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.36% |
| 2 | Healthcare | 14.16% |
| 3 | Communication Services | 14.01% |
| 4 | Consumer Staples | 10.33% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLLS
26
Cellectis
CLLS
$277M
| $1.13M | 1.14% |
40,000
+26,500
| +196% | +$789K |
|
27
Galmed Pharmaceuticals
GLMD
$5.13M
| $1.13M | 1.14% |
528
-28
| -5% | -$40.5K |
|
|
CCXI
28
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.12M | 1.13% |
85,000
+10,000
| +13% | +$120K |
|
|
EIGR
29
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.1M | 1.11% |
3,000
-1,500
| -33% | -$534K |
|
30
LendingTree
TREE
$447M
| $1.07M | 1.08% |
5,000
| – | – |
|
|
31
Akebia Therapeutics
AKBA
$354M
| $998K | 1.01% |
+100,000
| New | +$1M |
|
|
ONCE
32
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $993K | 1% |
+12,000
| New | +$926K |
|
|
RDS.A
33
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $831K | 0.84% |
12,000
-500
| -4% | -$34.6K |
|
|
LKFT
34
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $830K | 0.84% |
9,000
| – | – |
|
35
Verizon
VZ
$195B
| $755K | 0.76% |
15,000
-1,500
| -9% | -$72.6K |
|
36
Kraft Heinz
KHC
$30.7B
| $691K | 0.7% |
+11,000
| New | +$653K |
|
37
Altria Group
MO
$114B
| $681K | 0.69% |
12,000
+2,000
| +20% | +$115K |
|
38
Merck
MRK
$322B
| $668K | 0.67% |
11,528
-1,048
| -8% | -$59.1K |
|
39
Johnson & Johnson
JNJ
$618B
| $667K | 0.67% |
5,500
+500
| +10% | +$62.4K |
|
40
DuPont de Nemours
DD
$18.5B
| $659K | 0.67% |
3,949
| – | – |
|
41
Coca-Cola
KO
$377B
| $658K | 0.66% |
15,000
| – | – |
|
42
PepsiCo
PEP
$190B
| $653K | 0.66% |
6,000
| – | – |
|
43
Pfizer
PFE
$143B
| $653K | 0.66% |
18,972
-2,108
| -10% | -$72K |
|
44
Philip Morris
PM
$297B
| $646K | 0.65% |
8,000
+1,000
| +14% | +$84.9K |
|
45
GSK
GSK
$104B
| $645K | 0.65% |
12,800
| – | – |
|
46
BP
BP
$116B
| $639K | 0.65% |
14,874
-2,346
| -14% | -$98.6K |
|
47
Chevron
CVX
$392B
| $632K | 0.64% |
5,000
-500
| -9% | -$62.1K |
|
48
Procter & Gamble
PG
$336B
| $624K | 0.63% |
8,000
+500
| +7% | +$37.6K |
|
49
Omega Healthcare
OHI
$15.1B
| $620K | 0.63% |
20,000
-5,000
| -20% | -$143K |
|
50
ExxonMobil
XOM
$644B
| $620K | 0.63% |
+7,500
| New | +$598K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q2 2018 Portfolio in Review
As of Q2 2018, P.A.W. Capital held 71 positions worth $99M, up 19% from $83.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
P.A.W. Capital deployed $7.99M of net new capital in Q2 2018, opening 10 new positions and adding to 19 existing holdings. Its largest new stake was Semler Scientific: 90,000 shares worth $1.39M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was R1 RCM Inc. Common Stock, an estimated $809K trimmed.
- P.A.W. Capital's largest Q2 2018 buy was Semler Scientific: 90,000 shares worth $1.39M.
- P.A.W. Capital added most to Electronics for Imaging in Q2 2018, an estimated $1.27M increase.
- P.A.W. Capital's biggest Q2 2018 reduction was R1 RCM Inc. Common Stock, cutting an estimated $809K.
- P.A.W. Capital fully exited Web.com Group, Inc. in Q2 2018, selling an estimated $2.17M.
- P.A.W. Capital's ten largest holdings make up 41% of its $99M portfolio in Q2 2018.
- P.A.W. Capital opened 10 new positions and closed 7 in Q2 2018.
- P.A.W. Capital's portfolio value rose 19% quarter-over-quarter to $99M.
Based on P.A.W. Capital's 13F filing for Q2 2018, filed 25 Jul 2018.